Skip to main content

PROF. B.L. Feringa

SUMMARY

Ben L. Feringa obtained his PhD degree at the University of Groningen in the Netherlands under the guidance of Professor Hans Wynberg. After working as a research scientist at Shell in the Netherlands and the UK, he was appointed lecturer and in 1988 full professor at the University of Groningen and named the Jacobus H. van't Hoff Distinguished Professor of Molecular Sciences in 2004. He was elected Foreign Honory member of the American Academy of Arts and Sciences and member and vice-president of the Royal Netherlands Academy of Sciences. Ben Feringa is member of Council of the RSC. In 2008 he was appointed Academy Professor and was knighted by Her Majesty the Queen of the Netherlands. Feringa’s research has been recognized with a number of awards including the Koerber European Science Award (2003), the Spinoza Award (2004), the Prelog gold medal (2005), the Norrish Award of the ACS (2007), the Paracelsus medal (2008), the Chirality medal (2009),the RSC Organic Stereochemistry Award (2011), Humboldt award (2012), the Nagoya gold medal (2013), ACS Cope Scholar Award 2015, Chemistry for the Future Solvay Prize (2015), the August-Wilhelm-von-Hoffman Medal (2016), The 2016 Nobel prize in Chemistry and the Tetrahedron Prize 2017. Feringa’s research interest includes stereochemistry, organic synthesis, asymmetric catalysis, molecular switches and motors, self-assembly, molecular nanosystems and photopharmacology.

Ben L. Feringa PROF. Ben L. Feringa

PROF. Ben L. Feringa
Jacobus van ’t Hoff Distinguished Professor of Molecular
Sciences
Stratingh Institute for Chemistry, Centre for Systems
Chemistry & Zernike Institute for Advanced
Materials University of Groningen
Nijenborgh 4, 9747 AG Groningen,
The Netherlands

Last updated: Sept. 1, 2019

The Jury

PROF. B.L. Feringa President of the jury,
University of Groningen, The Netherlands
PROF. J. Cossy ESPCI, Paris (France)
PROF. DR. A. Fürstner Max-Planck-Institute für Kohlenforschung - Germany
PROF. V. Gouverneur University of Oxford, UK
PROF. P. Herdewijn Rega Institute for Medical Sciences Katholieke Universiteit Leuven, Belgium
PROF. K.C. Nicolaou Rice University, USA
PROF. S. Kobayashi President, University of Tokyo, Japan
PROF. E. N. Jacobsen Harvard University, USA
Dr Hilmar Weinmann Secretary of the Jury, Janssen Pharmaceutical Companies of J&J, Belgium